SCHEMBL15445265

SCHEMBL15445265

C=CC(=O)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.80
ERBB2 P04626 7/20 0.80
ERBB4 Q15303 4/20 0.80
KIT P10721 3/20 0.80
SRC P12931 3/20 0.80
ERBB3 P21860 3/20 0.80
CIT O14578 2/20 0.80
GAK O14976 2/20 0.80
EPHB6 O15197 2/20 0.80
RIPK2 O43353 2/20 0.80
STK17B O94768 2/20 0.80
STK10 O94804 2/20 0.80
ABL1 P00519 2/20 0.80
LCK P06239 2/20 0.80
LYN P07948 2/20 0.80
RET P07949 2/20 0.80
MET P08581 2/20 0.80
HCK P08631 2/20 0.80
FGR P09769 2/20 0.80
EPHA1 P21709 2/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20931182 0.90 EGFR (0.77) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL54837 0.89 EGFR (1.00) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL29368458 0.89 EGFR (1.00) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL29623482 0.89 EGFR (1.00) EGFRERBB2ERBB4KITSRC
SCHEMBL27679722 0.89 EGFR (0.64) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL29655741 0.89 EGFR (1.00) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL30436576 0.88 EGFR (1.00) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL2141065 0.88 EGFR (1.00) EGFRERBB2ERBB4KITSRC
Canertinib SCHEMBL2052123 0.88 EGFR (1.00) EGFRERBB2ERBB4KITSRC
SCHEMBL29577833 0.88 EGFR (0.92) EGFRERBB2ERBB4KITSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2698733-A1 USES OF MULTI-DIMENSIONAL MATRIX IN PHARMACEUTICAL MOLECULE DESIGN AND PHARMACEUTICAL MOLECULE DESIGN METHOD Yan, Jingbo (CN) 2014-02-19 EP disclosed
US-20140032198-A1 APPLICATION OF MULTIDIMENSIONAL MATRIX FOR DRUG MOLECULAS DESIGN AND THE METHODOLOGIES FOR DRUG MOLECULAR DESIGN YAN JINGBO (CN) 2014-01-30 US disclosed
US-20140032198-A1 APPLICATION OF MULTIDIMENSIONAL MATRIX FOR DRUG MOLECULAS DESIGN AND THE METHODOLOGIES FOR DRUG MOLECULAR DESIGN YAN JINGBO (CN) 2014-01-30 US disclosed